These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 18193805)
1. [Pharmacology of beta blockers]. Kazić T Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():5-9. PubMed ID: 18193805 [TBL] [Abstract][Full Text] [Related]
2. Evolving mechanisms of action of beta blockers: focus on nebivolol. Mason RP; Giles TD; Sowers JR J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811 [TBL] [Abstract][Full Text] [Related]
3. Use of beta-blockers in patients with an implantable cardioverter defibrillator. LaPointe NM; Stafford JA; Pappas PA; Al-Khatib SM; Anstrom KJ Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655 [TBL] [Abstract][Full Text] [Related]
4. [The present status and prospects of therapeutic use of beta-blockers in diseases of the cardiovascular system]. Kuzelová M; Svec P Ceska Slov Farm; 1998 Feb; 47(1):4-9. PubMed ID: 9600149 [TBL] [Abstract][Full Text] [Related]
5. [New beta-blockers in the treatment of chronic ischaemic heart disease]. Jankowski P; Kawecka-Jaszcz K; Jastrzebski M Przegl Lek; 2004; 61(9):955-61. PubMed ID: 15803908 [TBL] [Abstract][Full Text] [Related]
6. [Principal pharmacological properties of different beta-blockers, possibilities and new perspectives of their uses]. Antelava N; Antelava A; Pachkoria K; Pirtskhalaishvili N Georgian Med News; 2006 Dec; (141):38-46. PubMed ID: 17261885 [TBL] [Abstract][Full Text] [Related]
8. [Relevant pharmacologic data as a guide for use of beta-blockers in psychiatry]. Heim A; Vanelle JM Encephale; 1992; 18(6):665-7. PubMed ID: 1364155 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of beta blockers: a class action or individual pharmacologic spectrum? Harrison DC Circulation; 1983 Jun; 67(6 Pt 2):I77-82. PubMed ID: 6133648 [TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy. Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A; Cury PM Am Heart J; 2008 Sep; 156(3):422-30. PubMed ID: 18760121 [TBL] [Abstract][Full Text] [Related]
15. Models for evaluating the pharmacokinetics and pharmacodynamics for β-blockers. Höcht C; Bertera FM; Del Mauro JS; Taira CA Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):525-41. PubMed ID: 24593316 [TBL] [Abstract][Full Text] [Related]
16. Update on beta blockers. Williams JR AANA J; 1989 Feb; 57(1):29-36. PubMed ID: 2564714 [TBL] [Abstract][Full Text] [Related]
17. Stereochemical comparison of nebivolol with other beta-blockers. Siebert CD; Hänsicke A; Nagel T Chirality; 2008 Feb; 20(2):103-9. PubMed ID: 18072266 [TBL] [Abstract][Full Text] [Related]
18. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension? Kountz DS Postgrad Med; 2009 Jan; 121(1):14-24. PubMed ID: 19179810 [TBL] [Abstract][Full Text] [Related]
19. Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis. Bangalore S; Wild D; Parkar S; Kukin M; Messerli FH J Am Coll Cardiol; 2008 Sep; 52(13):1062-72. PubMed ID: 18848139 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial). Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]